InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,099.96
(
1.02%
)
US TECH 100
17,236.00
(
1.52%
)
Dow Jones
38,239.66
(
0.40%
)
Brent Oil
88.17
(
0.02%
)
Bitcoin
63,766.46
(
-1.11%
)
Post# of 643
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Report Keyboard Shortcuts
Prev Next

bobhorger

Send PM Follow Ignore
Followers 0
Posts 1
Boards Moderated 0
Alias Born 03/26/2010

bobhorger

Re: None

Sunday, 12/22/2013 8:37:13 PM

Sunday, December 22, 2013 8:37:13 PM

Post# of 643
I need some help here. I still hold a sizeable amount of BPMA. Recently it became delisted because BPMA failed to file their 10Q etc. although they did file notice of their settlement with POPE.


As you may know, Benda Pharmaceuticals (BPMA) owns 60% of Sibiono, the developer of Gendicine. After research, I discovered that Sibiono (the developer of Gendicine) had secured financing to buy BPMA's Hong Kong exchange shares for .20/share.

My question is how does this reansaction affect my shares purchased through and held in my Schwab account?

The Chinese website handling the financing of the acquisition is:

http://www.352.cn/trading3/webTradingRzbDetail.do?id=985###

Please respond to my email bobmat@austin.rr.com

Thanks
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Report Keyboard Shortcuts
Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up